•  
  •  
  •  
  •  

2025-08-31 16:15:06

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism

Keywords Selected:  DishmanCarbogenAmcis

Stock Report

  • CARBOGEN AMCIS AG., has entered into a co-investment agreement of more than CHF 25 million with a key client to expand Swiss sites
  • CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA
  • CARBOGEN AMCIS (Shanghai) Co Ltd. has successfully completed ANVISA Audit of its facility in Shanghai, China
  • Dishman Carbogen Amcis Ltd updates on USFDA inspection at its Bavla facility
  • Dishman Carbogen Amcis Limited updates on inspection by EDQM and AIFA
  • Dishman Carbogen Amcis Ltd consolidated Q1 FY2024 PAT at Rs. 17 crores
  • Dishman Carbogen Amcis Ltd Q4 FY2023 consolidated loss at Rs. 70.72 crores
  • Dishman Carbogen Amcis Ltd's subsidiary completes USFDA inspection at its Bubendorf facility
  • Dishman Carbogen Amcis Ltd consolidated Q3FY23 net profit up at Rs. 4.69 crores
  • CARBOGEN AMCIS SAS opens new state-of-the-art facility in SaintBeauzire, France
  • Dishman Carbogen Amcis Ltd updates on rating
  • CARBOGEN AMCIS AG. has successfully completed Swissmedic inspection of its facility in Vionnaz, Switzerland
  • Dishman Carbogen Amcis Ltd Q4 FY2022 consolidated loss at Rs. 44.62 crores
  • CARBOGEN AMCIS entities appoint Pascal Villemagne as new Chief Executive Officer
  • Dishman Carbogen Amcis Ltd Q3FY22 consolidated PAT up at Rs. 35.38 crores
  • Dishman Carbogen Amcis Ltd Q2FY22 consolidated PAT at Rs. 11.19 crores
  • NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS
  • CARBOGEN AMCIS AG. has successfully completed U.S. FDA inspection of its facility in Aarau, Switzerland

Latest Post

  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024